38.53
price up icon15.26%   5.10
after-market 시간 외 거래: 38.08 -0.45 -1.17%
loading
전일 마감가:
$33.43
열려 있는:
$31.7
하루 거래량:
71,257
Relative Volume:
1.38
시가총액:
$204.01M
수익:
-
순이익/손실:
$-7.12M
주가수익비율:
-16.75
EPS:
-2.3
순현금흐름:
$-6.82M
1주 성능:
+1.13%
1개월 성능:
+9.74%
6개월 성능:
+694.43%
1년 성능:
+5,920%
1일 변동 폭
Value
$31.70
$42.00
1주일 범위
Value
$31.70
$43.00
52주 변동 폭
Value
$0.3438
$54.30

Monopar Therapeutics Inc Stock (MNPR) Company Profile

Name
명칭
Monopar Therapeutics Inc
Name
전화
(847) 388-0349
Name
주소
1000 SKOKIE BLVD SUITE 350, WILMETTE
Name
직원
12
Name
트위터
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
MNPR's Discussions on Twitter

MNPR을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
MNPR
Monopar Therapeutics Inc
38.53 204.01M 0 -7.12M -6.82M -2.30
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
483.49 124.48B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
625.60 67.45B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
583.62 35.60B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
266.83 34.53B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
274.78 29.15B 3.81B -644.79M -669.77M -6.24

Monopar Therapeutics Inc Stock (MNPR) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-03-19 재개 Piper Sandler Overweight
2025-01-10 개시 Piper Sandler Overweight
2024-10-11 개시 Rodman & Renshaw Buy
2021-01-28 개시 ROTH Capital Buy

Monopar Therapeutics Inc 주식(MNPR)의 최신 뉴스

pulisher
12:01 PM

Monopar Therapeutics downgraded to Hold from Buy at JonesResearch - TipRanks

12:01 PM
pulisher
07:40 AM

We Think Monopar Therapeutics (NASDAQ:MNPR) Can Easily Afford To Drive Business Growth - Yahoo Finance

07:40 AM
pulisher
04:30 AM

Monopar Therapeutics (NASDAQ:MNPR) Receives “Buy” Rating from HC Wainwright - Defense World

04:30 AM
pulisher
Apr 01, 2025

Monopar Therapeutics Stock Hits 52-Week High at $38.91 - MSN

Apr 01, 2025
pulisher
Apr 01, 2025

Monopar Therapeutics Inc: Strategic Advancements and Promising Financial Projections Justify Buy Rating - TipRanks

Apr 01, 2025
pulisher
Mar 31, 2025

Monopar Therapeutics reports Q4 EPS ($2.23) vs. (60c) last year - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

Monopar Therapeutics sees cash runway through December 31, 2026 - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

Monopar Therapeutics SEC 10-K Report - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

Monopar Secures 2-Year Runway with $60M War Chest, Advances Wilson Disease Drug - Stock Titan

Mar 31, 2025
pulisher
Mar 27, 2025

MNPR Stock Price and Chart — NASDAQ:MNPR - TradingView

Mar 27, 2025
pulisher
Mar 21, 2025

Here's Why Momentum in Monopar Therapeutics (MNPR) Should Keep going - Yahoo Finance

Mar 21, 2025
pulisher
Mar 21, 2025

Piper Sandler Reaffirms “Overweight” Rating for Monopar Therapeutics (NASDAQ:MNPR) - Defense World

Mar 21, 2025
pulisher
Mar 20, 2025

Monopar Therapeutics (MNPR) to Release Quarterly Earnings on Thursday - Defense World

Mar 20, 2025
pulisher
Mar 19, 2025

Monopar a new overweight at Piper Sandler on rare disease asset - Seeking Alpha

Mar 19, 2025
pulisher
Mar 19, 2025

Piper Sandler sets Monopar stock at $76 with Overweight rating - Investing.com

Mar 19, 2025
pulisher
Mar 19, 2025

Buy Rating for Monopar Therapeutics Inc. Driven by Strategic Acquisition and ALXN1840 Potential - TipRanks

Mar 19, 2025
pulisher
Mar 19, 2025

Piper Sandler sets Monopar stock at $76 with Overweight rating By Investing.com - Investing.com UK

Mar 19, 2025
pulisher
Mar 16, 2025

(MNPR) Trading Report - news.stocktradersdaily.com

Mar 16, 2025
pulisher
Mar 08, 2025

Monopar Therapeutics Inc.'s (NASDAQ:MNPR) 19% loss last week hit both individual investors who own 33% as well as institutions - Simply Wall St

Mar 08, 2025
pulisher
Mar 04, 2025

Monopar Therapeutics: Strong Data, But There Are Risks (NASDAQ:MNPR) - Seeking Alpha

Mar 04, 2025
pulisher
Mar 03, 2025

Monopar Therapeutics appoints new CFO - Investing.com

Mar 03, 2025
pulisher
Mar 03, 2025

Monopar Therapeutics Appoints Quan Vu as New CFO - TipRanks

Mar 03, 2025
pulisher
Mar 03, 2025

Monopar Therapeutics Inc Says On Feb 28, CFO Karthik Radhakrishnan'S Employment Terminated - Marketscreener.com

Mar 03, 2025
pulisher
Mar 03, 2025

Monopar Therapeutics appoints new CFO By Investing.com - Investing.com Australia

Mar 03, 2025
pulisher
Feb 24, 2025

Monopar Therapeutics appoints new board member - Investing.com

Feb 24, 2025
pulisher
Feb 24, 2025

Monopar Therapeutics appoints new board member By Investing.com - Investing.com UK

Feb 24, 2025
pulisher
Feb 24, 2025

Monopar Therapeutics Appoints Lavina Talukdar to Board - TipRanks

Feb 24, 2025
pulisher
Feb 23, 2025

Trend Tracker for (MNPR) - Stock Traders Daily

Feb 23, 2025
pulisher
Feb 19, 2025

Copper wired: Monopar to electrify Wilson disease? - BioWorld Online

Feb 19, 2025
pulisher
Feb 13, 2025

Q1 EPS Estimate for Monopar Therapeutics Raised by Analyst - MarketBeat

Feb 13, 2025
pulisher
Feb 12, 2025

Learn to Evaluate (MNPR) using the Charts - Stock Traders Daily

Feb 12, 2025
pulisher
Feb 11, 2025

Brookline Capital Management Forecasts MNPR Q1 Earnings - Defense World

Feb 11, 2025
pulisher
Feb 06, 2025

Monopar's Incredible Journey From $5 To $50 In Less Than 5 Months - RTTNews

Feb 06, 2025
pulisher
Feb 04, 2025

Why Monopar Therapeutics Inc (MNPR) Is Skyrocketing So Far In 2025 - MSN

Feb 04, 2025
pulisher
Feb 03, 2025

Why These 15 Healthcare Stocks Are Skyrocketing So Far In 2025 - Insider Monkey

Feb 03, 2025
pulisher
Jan 27, 2025

What's Going On With Cancer-Focused Monopar Therapeutics Stock Today? - MSN

Jan 27, 2025
pulisher
Jan 26, 2025

What is HC Wainwright’s Forecast for MNPR FY2026 Earnings? - Defense World

Jan 26, 2025
pulisher
Jan 24, 2025

Analysts Set Expectations for MNPR FY2029 Earnings - MarketBeat

Jan 24, 2025
pulisher
Jan 24, 2025

What is HC Wainwright's Forecast for MNPR FY2026 Earnings? - MarketBeat

Jan 24, 2025
pulisher
Jan 24, 2025

Monopar Therapeutics Stock Hits 52-Week High at $38.91 By Investing.com - Investing.com South Africa

Jan 24, 2025
pulisher
Jan 23, 2025

Rosalind Franklin University's Helix 51 Incubator Welcomes Monopar Therapeutics - PR Newswire

Jan 23, 2025
pulisher
Jan 23, 2025

Monopar Therapeutics price target raised to $40 from $22 at H.C. Wainwright - Yahoo Finance

Jan 23, 2025
pulisher
Jan 23, 2025

Monopar Therapeutics Joins Elite Helix 51 Biomedical Hub to Accelerate Cancer Treatment Research - Stock Titan

Jan 23, 2025
pulisher
Jan 22, 2025

Monopar Therapeutics (NASDAQ:MNPR) Price Target Raised to $40.00 - MarketBeat

Jan 22, 2025
pulisher
Jan 21, 2025

All You Need to Know About Monopar Therapeutics (MNPR) Rating Upgrade to Buy - MSN

Jan 21, 2025
pulisher
Jan 21, 2025

Up 1,000% in 2024, Wall Street Believes This Growth Stock Can Still Skyrocket - MSN

Jan 21, 2025
pulisher
Jan 12, 2025

Piper Sandler Begins Coverage on Monopar Therapeutics (NASDAQ:MNPR) - Defense World

Jan 12, 2025

Monopar Therapeutics Inc (MNPR) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$73.44
price up icon 2.00%
$68.32
price up icon 0.56%
$31.28
price up icon 0.35%
$20.46
price up icon 8.83%
$93.32
price up icon 3.36%
biotechnology ONC
$274.78
price up icon 1.38%
자본화:     |  볼륨(24시간):